Latest Breaking News On - Company media enquiries - Page 1 : comparemela.com
Global retina expert joins to support sozinibercept development and launch preparationMELBOURNE, Australia, Feb. 19, 2024 (GLOBE NEWSWIRE) Opthea Limited (ASX:OPT; NASDAQ:OPT, “Opthea”), a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, today announced the appointment of Arshad M. Khanani, MD, MA, FASRS, as Chief Medical Advisor. An internationally recognized retina specialist and clinical scientist, Dr. Khanani i
University-of-nevadaNevadaUnited-statesAustraliaMelbourneVictoriaAmericanFrederic-guerardArshadm-khananiRudi-michelsonMacula-societyOpthea-limited